News &amp; Updates

One in six patients with coeliac disease (CD) do not have a reliable access to a sufficient amount of affordable and nutrition food, a US study has found. This food insecurity negatively affects the adoption of a gluten-free diet (GFD) and the ability to meet recommended daily intake of most micronutrients.

SGLT2i cuts cardiovascular, renal risk in diabetics

Compared with dipeptidyl peptidase-4 inhibitors (DPP4i), the use of sodium glucose co-transporter 2 inhibitors (SGLT2i) is associated with lower risk of cardiovascular disease, renal events, and heart failure (HF) hospitalization among patients with diabetes, reports a recent study.

22 Oct 2022

Male shift workers have poorer oral health

Dental caries and periodontal diseases appear to be more common among male shift workers, pointing to a potential negative impact of working conditions on oral health, reports a recent study.

Hysterectomy tied to increased diabetes risk

Undergoing a hysterectomy, particularly at a young age, may be associated with an increased risk of developing diabetes, according to a study from France presented at EASD 2022.

21 Oct 2022

Hormone therapy carries risk of slight BP elevations in hypertensive postmenopausal women

The use of hormone therapy poses a small but significant increase in systolic blood pressure (BP) in postmenopausal women with hypertension, a study has found. However, this BP elevation does not lead to increased BP-lowering medication use over time.

Reduced-fat vegan diet plus daily soybeans: Foods with benefits for postmenopausal women

A dietary intervention consisting of a plant-based diet, minimal oils, and daily soybeans appears to have favourable effects on vasomotor symptoms and menopause-related quality of life, as reported in a study.

MELD-Na predicts 6-month mortality in decompensated cirrhosis patients

A score of 28 in the Model of End-stage Liver Disease—Sodium (MELD-Na), an objective measure to identify patients with decompensated cirrhosis who are at increased risk of 6-month mortality in time-constrained settings, may prompt talks about hospice to improve value-based healthcare in these individuals, suggests a recent study.

Long-term tapinarof use proven safe, effective in plaque psoriasis

Continuous and intermittent use of tapinarof cream 1% once daily (QD) for up to 1 year is effective in patients with mild-to-severe plaque psoriasis, without serious safety concerns, according to a study. In addition, it has shown durable efficacy and a remittive effect of at least 4 months off therapy.

21 Oct 2022

Tofacitinib effective in ulcerative colitis, but higher doses lead to adverse events

The overall efficacy and safety of tofacitinib in moderate-to-severe ulcerative colitis (UC) agree with clinical trial data, but a dose-dependent increase in adverse events (AEs) occurs, which underscores the importance of early dose de-escalation, according to a study.

Peanut intake may help with weight loss